Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York
- PMID: 28403435
- PMCID: PMC5815031
- DOI: 10.1001/jamacardio.2017.0491
Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York
Abstract
Importance: Trans-fatty acids (TFAs) have deleterious cardiovascular effects. Restrictions on their use were initiated in 11 New York State (NYS) counties between 2007 and 2011. The US Food and Drug Administration plans a nationwide restriction in 2018. Public health implications of TFA restrictions are not well understood.
Objective: To determine whether TFA restrictions in NYS counties were associated with fewer hospital admissions for myocardial infarction (MI) and stroke compared with NYS counties without restrictions.
Design, setting, and participants: We conducted a retrospective observational pre-post study of residents in counties with TFA restrictions vs counties without restrictions from 2002 to 2013 using NYS Department of Health's Statewide Planning and Research Cooperative System and census population estimates. In this natural experiment, we included those residents who were hospitalized for MI or stroke. The data analysis was conducted from December 2014 through July 2016.
Exposure: Residing in a county where TFAs were restricted.
Main outcomes and measures: The primary outcome was a composite of MI and stroke events based on primary discharge diagnostic codes from hospital admissions in NYS. Admission rates were calculated by year, age, sex, and county of residence. A difference-in-differences regression design was used to compare admission rates in populations with and without TFA restrictions. Restrictions were only implemented in highly urban counties, based on US Department of Agriculture Economic Research Service Urban Influence Codes. Nonrestriction counties of similar urbanicity were chosen to make a comparison population. Temporal trends and county characteristics were accounted for using fixed effects by county and year, as well as linear time trends by county. We adjusted for age, sex, and commuting between restriction and nonrestriction counties.
Results: In 2006, the year before the first restrictions were implemented, there were 8.4 million adults (53.6% female) in highly urban counties with TFA restrictions and 3.3 million adults (52.3% female) in highly urban counties without restrictions. Twenty-five counties were included in the nonrestriction population and 11 in the restriction population. Three or more years after restriction implementation, the population with TFA restrictions experienced significant additional decline beyond temporal trends in MI and stroke events combined (-6.2%; 95% CI, -9.2% to -3.2%; P < .001) and MI (-7.8%; 95% CI, -12.7% to -2.8%; P = .002) and a nonsignificant decline in stroke (-3.6%; 95% CI, -7.6% to 0.4%; P = .08) compared with the nonrestriction populations.
Conclusions and relevance: The NYS populations with TFA restrictions experienced fewer cardiovascular events, beyond temporal trends, compared with those without restrictions.
Conflict of interest statement
Figures
Similar articles
-
Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban.Am J Public Health. 2007 Nov;97(11):2035-9. doi: 10.2105/AJPH.2006.099994. Epub 2007 Sep 27. Am J Public Health. 2007. PMID: 17901438 Free PMC article.
-
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.JAMA Cardiol. 2017 Jul 1;2(7):750-757. doi: 10.1001/jamacardio.2017.1460. JAMA Cardiol. 2017. PMID: 28538984 Free PMC article.
-
Relationship between COVID-19 cases and vaccination rates in New York State counties.Ann Fam Med. 2022 Apr 1;20(20 Suppl 1):3134. doi: 10.1370/afm.20.s1.3134. Ann Fam Med. 2022. PMID: 36706247 Free PMC article.
-
Trans fatty acids linked to myocardial infarction and stroke: What is the evidence?Trends Cardiovasc Med. 2019 Jul;29(5):306-310. doi: 10.1016/j.tcm.2018.09.011. Epub 2018 Sep 19. Trends Cardiovasc Med. 2019. PMID: 31130187 Review.
-
Health effects of trans-fatty acids: experimental and observational evidence.Eur J Clin Nutr. 2009 May;63 Suppl 2:S5-21. doi: 10.1038/sj.ejcn.1602973. Eur J Clin Nutr. 2009. PMID: 19424218 Review.
Cited by
-
Ending Trans Fat-The First-Ever Global Elimination Program for a Noncommunicable Disease Risk Factor: JACC International.J Am Coll Cardiol. 2024 Aug 13;84(7):663-674. doi: 10.1016/j.jacc.2024.04.067. J Am Coll Cardiol. 2024. PMID: 39111974 Free PMC article. Review.
-
Western diets and chronic diseases.Nat Med. 2024 Aug;30(8):2133-2147. doi: 10.1038/s41591-024-03165-6. Epub 2024 Jul 31. Nat Med. 2024. PMID: 39085420 Review.
-
Cities as Platforms for Population Health: Past, Present, and Future.Milbank Q. 2023 Apr;101(S1):242-282. doi: 10.1111/1468-0009.12612. Milbank Q. 2023. PMID: 37096598 Free PMC article.
-
Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides.Int J Mol Sci. 2023 Feb 23;24(5):4403. doi: 10.3390/ijms24054403. Int J Mol Sci. 2023. PMID: 36901834 Free PMC article. Review.
-
Food, nutrition and diet in urban areas from low- and middle-income countries in the WHO European Region.Public Health Nutr. 2023 Dec;26(S1):s1-s5. doi: 10.1017/S1368980022002051. Epub 2022 Sep 20. Public Health Nutr. 2023. PMID: 36123324 Free PMC article. No abstract available.
References
-
- Doell D, Folmer D, Lee H, Honigfort M, Carberry S. Updated estimate of trans fat intake by the US population. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(6):861-874. - PubMed
-
- Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354(15):1601-1613. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
